{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:28:31Z","timestamp":1791001711524,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"INTRAMURAL GRANT FROM KGMU","award":["467\/R.cell-19 dated: 24\/06\/2019"],"award-info":[{"award-number":["467\/R.cell-19 dated: 24\/06\/2019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-021-04883-7","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T17:10:49Z","timestamp":1622135449000},"page":"1431-1441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical, radiologic and serologic profile of patients with interstitial pneumonia with autoimmune features: a cross-sectional study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7579-136X","authenticated-orcid":false,"given":"Kasturi","family":"Hazarika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6616-4989","authenticated-orcid":false,"given":"Rasmi Ranjan","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3043-1218","authenticated-orcid":false,"given":"Namita","family":"Mohindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Wakhlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4031-136X","authenticated-orcid":false,"given":"Manesh","family":"Manoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9424-6412","authenticated-orcid":false,"given":"Prashant","family":"Bafna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5564-8037","authenticated-orcid":false,"given":"Rajiv","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7396","authenticated-orcid":false,"given":"Durga Prasanna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4342-9547","authenticated-orcid":false,"given":"Anupam","family":"Wakhlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"4883_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society\/European Respiratory Society","year":"2002","unstructured":"American Thoracic Society\/European Respiratory Society (2002) International multidisciplinary consensus classification of the idiopathic interstitial pneumonias: this joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277\u2013304","journal-title":"Am J Respir Crit Care Med"},{"key":"4883_CR2","first-page":"381","volume":"37","author":"PL Haslam","year":"1979","unstructured":"Haslam PL, Thompson B, Mohammed I, Townsend PJ, Hodson ME, Holborow EJ et al (1979) Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol 37:381\u2013390","journal-title":"Clin Exp Immunol"},{"key":"4883_CR3","first-page":"379","volume":"20","author":"P Haslam","year":"1975","unstructured":"Haslam P, Turner-Warwick M, Lukoszek A (1975) Antinuclear antibody and lymphocyte responses to nuclear antigens in patients with lung disease. Clin Exp Immunol 20:379\u2013395","journal-title":"Clin Exp Immunol"},{"key":"4883_CR4","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1378\/chest.10-2662","volume":"140","author":"R Vij","year":"2011","unstructured":"Vij R, Noth I, Strek ME (2011) Autoimmune-featured interstitial lung disease. Chest 140:1292\u20131299","journal-title":"Chest"},{"key":"4883_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1378\/chest.10-0194","volume":"138","author":"A Fischer","year":"2010","unstructured":"Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM (2010) Connective tissue disease-associated interstitial lung disease. Chest 138:251\u2013256","journal-title":"Chest"},{"key":"4883_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1183\/09031936.00174910","volume":"39","author":"TJ Corte","year":"2012","unstructured":"Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG et al (2012) Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 39:661\u2013668","journal-title":"Eur Respir J"},{"key":"4883_CR7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM et al (2015) An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46:976\u2013987","journal-title":"Eur Respir J"},{"key":"4883_CR8","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO et al (2010) 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"4883_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/rheumatology\/keh671","volume":"44","author":"FA Wollheim","year":"2005","unstructured":"Wollheim FA (2005) Classification of systemic sclerosis. Visions and reality Rheumatol Oxf Engl 44:1212\u20131216","journal-title":"Visions and reality Rheumatol Oxf Engl"},{"key":"4883_CR10","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R et al (2019) 2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71:1400\u20131412","journal-title":"Arthritis Rheumatol"},{"key":"4883_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM et al (2017) 2016 ACR-EULAR classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol Hoboken NJ 69:35\u201345","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"4883_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000507","author":"M Bottai","year":"2017","unstructured":"Bottai M, Tj\u00e4rnlund A, Santoni G, Werth VP, Pilkington C, de Visser M et al (2017) EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies their major subgroups: a methodology report. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2017-000507","journal-title":"RMD Open"},{"key":"4883_CR13","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir 53:1801913. https:\/\/doi.org\/10.1183\/13993003.01913-2018","journal-title":"Eur Respir"},{"key":"4883_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.echo.2016.08.013","volume":"29","author":"PT Levy","year":"2016","unstructured":"Levy PT, Patel MD, Groh G, Choudhry S, Murphy J, Holland MR et al (2016) Pulmonary artery acceleration time provides a reliable estimate of invasive pulmonary hemodynamics in children. J Am Soc Echocardiogr 29:1056\u20131065","journal-title":"J Am Soc Echocardiogr"},{"key":"4883_CR15","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1183\/13993003.01565-2015","volume":"47","author":"JM Oldham","year":"2016","unstructured":"Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L et al (2016) Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 47:1767\u20131775","journal-title":"Eur Respir J"},{"key":"4883_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.rmed.2016.09.002","volume":"119","author":"S Chartrand","year":"2016","unstructured":"Chartrand S, Swigris JJ, Stanchev L, Lee JS, Brown KK, Fischer A (2016) Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience. Respir Med 119:150\u2013154","journal-title":"Respir Med"},{"key":"4883_CR17","doi-asserted-by":"publisher","first-page":"A456","DOI":"10.1016\/j.chest.2016.02.475","volume":"149","author":"R Sharma","year":"2016","unstructured":"Sharma R, Talwar D, Tuteja M (2016) Clinico-radiological and autoimmune profile correlation in patients with autoimmune featured interstitial lung disease (AIF-ILD): an observational study in Indian scenario. Chest 149:A456","journal-title":"Chest"},{"key":"4883_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12890-019-0868-9","volume":"19","author":"JU Lim","year":"2019","unstructured":"Lim JU, Gil BM, Kang HS, Oh J, Kim YH, Kwon SS (2019) Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis. BMC Pulm Med 19:120. https:\/\/doi.org\/10.1186\/s12890-019-0868-9","journal-title":"BMC Pulm Med"},{"key":"4883_CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/ijrc.ijrc_13_20","volume":"9","author":"RC Avala","year":"2020","unstructured":"Avala RC, Narahari NK, Kapoor A, Kakarla B, Varma R, Gongati PK (2020) Interstitial pneumonia with autoimmune features\u2014an observational study in a tertiary care institute from south India. Indian J Respir Care 9:209\u2013215","journal-title":"Indian J Respir Care"},{"key":"4883_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1164\/rccm.200702-220OC","volume":"176","author":"BW Kinder","year":"2007","unstructured":"Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B et al (2007) Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176:691\u2013697","journal-title":"Am J Respir Crit Care Med"},{"key":"4883_CR21","doi-asserted-by":"crossref","unstructured":"Carvajalino S, Reigada C, Johnson MJ, Dzingina M, Bajwah S (2018) Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review. BMC Pulm Med [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5964639. Accessed 12 Dec 2020","DOI":"10.1186\/s12890-018-0651-3"},{"key":"4883_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.rmed.2016.10.017","volume":"123","author":"K Ahmad","year":"2017","unstructured":"Ahmad K, Barba T, Gamondes D, Ginoux M, Khouatra C, Spagnolo P et al (2017) Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med 123:56\u201362","journal-title":"Respir Med"},{"key":"4883_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102451","author":"M Sebastiani","year":"2020","unstructured":"Sebastiani M, Cassone G, De Pasquale L, Cerri S, Della Casa G, Vacchi C et al (2020) Interstitial pneumonia with autoimmune features: a single center prospective follow-up study. Autoimmun Rev. https:\/\/doi.org\/10.1016\/j.autrev.2019.102451","journal-title":"Autoimmun Rev"},{"key":"4883_CR24","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1378\/chest.09-0444","volume":"136","author":"EJ Kim","year":"2009","unstructured":"Kim EJ, Collard HR, King TE (2009) Rheumatoid arthritis-associated interstitial lung disease. Chest 136:1397\u20131405","journal-title":"Chest"},{"key":"4883_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.31138\/mjr.31.3.330","volume":"31","author":"M Karampeli","year":"2020","unstructured":"Karampeli M, Thomas K, Flouda S, Chavatza A, Nikolopoulos D, Pieta A et al (2020) Interstitial pneumonia with autoimmune features (IPAF): a single-centre, prospective study. Mediterr J Rheumatol 31:330\u2013336","journal-title":"Mediterr J Rheumatol"},{"key":"4883_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fmed.2019.00209","volume":"6","author":"L Fernandes","year":"2019","unstructured":"Fernandes L, Nasser M, Ahmad K, Cottin V (2019) Interstitial pneumonia with autoimmune features (IPAF). Front Med 6:209. https:\/\/doi.org\/10.3389\/fmed.2019.00209","journal-title":"Front Med"},{"key":"4883_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12890-017-0453-z","volume":"17","author":"Y Ito","year":"2017","unstructured":"Ito Y, Arita M, Kumagai S, Takei R, Noyama M, Tokioka F et al (2017) Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features. BMC Pulm Med 17:111. https:\/\/doi.org\/10.1186\/s12890-017-0453-z","journal-title":"BMC Pulm Med"},{"key":"4883_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.chest.2018.08.1073","volume":"155","author":"JM Oldham","year":"2019","unstructured":"Oldham JM, Danoff SK (2019) COUNTERPOINT: does interstitial pneumonia with autoimmune features represent a distinct class of patients with idiopathic interstitial pneumonia? No. Chest 155:260\u2013263","journal-title":"Chest"},{"key":"4883_CR29","first-page":"2230","volume":"34","author":"VD Steen","year":"2007","unstructured":"Steen VD, Lucas M, Fertig N, Medsger TA (2007) Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody. J Rheumatol 34:2230\u20132235","journal-title":"J Rheumatol"},{"key":"4883_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1183\/09059180.00005512","volume":"22","author":"JJ Solomon","year":"2013","unstructured":"Solomon JJ, Olson AL, Fischer A, Bull T, Brown KK, Raghu G (2013) Scleroderma lung disease. Eur Respir Rev 22:6\u201319","journal-title":"Eur Respir Rev"},{"key":"4883_CR31","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/415272","author":"JP Ferreira","year":"2012","unstructured":"Ferreira JP, Almeida I, Marinho A, Cerveira C, Vasconcelos C (2012) Anti-Ro52 antibodies and interstitial lung disease in connective tissue diseases excluding scleroderma. ISRN Rheumatol. https:\/\/doi.org\/10.5402\/2012\/415272","journal-title":"ISRN Rheumatol"},{"key":"4883_CR32","unstructured":"Singh Y, Patil P, Longhurst H, Clarke G, Dasgupta B (2013) Isolated Anti-Ro52 Antibody \u2013 Significance and Clinical Association. ACR Meeting Abstracts. A2037. https:\/\/acrabstracts.org\/abstract\/isolated-anti-ro52-antibody-significance-and-clinical-association. Accessed 6 Dec 2020."},{"key":"4883_CR33","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1084\/jem.20090585","volume":"206","author":"A Espinosa","year":"2009","unstructured":"Espinosa A, Dardalhon V, Brauner S, Ambrosi A, Higgs R, Quintana FJ et al (2009) Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by dysregulating the IL-23\u2013Th17 pathway. J Exp Med 206:1661\u20131671","journal-title":"J Exp Med"},{"key":"4883_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000488358","volume":"96","author":"H Yamakawa","year":"2018","unstructured":"Yamakawa H, Hagiwara E, Kitamura H, Iwasawa T, Otoshi R, Aiko N et al (2018) Predictive factors for the long-term deterioration of pulmonary function in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies. Respiration 96:210\u2013221","journal-title":"Respiration"},{"key":"4883_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000489936","volume":"96","author":"V Tzilas","year":"2018","unstructured":"Tzilas V, Tzouvelekis A, Bouros E, Bouros D (2018) Prognosis of interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies: look in the middle. Respiration 96:207\u2013209","journal-title":"Respiration"},{"key":"4883_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","volume":"26","author":"AW Friedman","year":"1996","unstructured":"Friedman AW, Targoff IN, Arnett FC (1996) Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 26:459\u2013467","journal-title":"Semin Arthritis Rheum"},{"key":"4883_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.autrev.2015.09.003","volume":"15","author":"C Ferri","year":"2016","unstructured":"Ferri C, Manfredi A, Sebastiani M, Colaci M, Giuggioli D, Vacchi C et al (2016) Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease. Autoimmun Rev 15:61\u201370","journal-title":"Autoimmun Rev"},{"key":"4883_CR38","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/ard.2006.051391","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845\u2013851","journal-title":"Ann Rheum Dis"},{"key":"4883_CR39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/ard.2007.076679","volume":"67","author":"DS Majka","year":"2008","unstructured":"Majka DS, Deane KD, Parrish LA, Lazar AA, Baron AE, Walker CW et al (2008) The duration of pre-clinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis 67:801\u2013807","journal-title":"Ann Rheum Dis"},{"key":"4883_CR40","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","volume":"106","author":"A Fischer","year":"2012","unstructured":"Fischer A, Solomon JJ, du Bois RM, Deane KD, Olson AL, Fernandez-Perez ER et al (2012) Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 106:1040\u20131047","journal-title":"Respir Med"},{"key":"4883_CR41","doi-asserted-by":"crossref","unstructured":"Wilfong EM, Schroeder G, Barnado A, Annapureddy N, Crofford LJ, Dudenhofe RB (2020) Myositis and systemic sclerosis spectrum IPAF patients are more likely to respond favorably to immunosuppression. C22 ILD THERAPY III\/RAPiD: rapid abstract poster discussion session. Am J Respir Crit Care Med 201:A4561. https:\/\/www.atsjournals.org\/doi\/pdf\/https:\/\/doi.org\/10.1164\/ajrccmconference.2020.201.1_MeetingAbstracts.A4561. Accessed 12 Dec 2020","DOI":"10.1164\/ajrccm-conference.2020.201.1_MeetingAbstracts.A4561"},{"key":"4883_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/art.11484","volume":"50","author":"AH Kao","year":"2004","unstructured":"Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV (2004) Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 50:209\u2013215","journal-title":"Arthritis Rheum"},{"key":"4883_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EKL (2017) A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52:1\u201319","journal-title":"Clin Rev Allergy Immunol"},{"key":"4883_CR44","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/art.1780280711","volume":"28","author":"IN Targoff","year":"1985","unstructured":"Targoff IN, Reichlin M (1985) The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28:796\u2013803","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04883-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:23:36Z","timestamp":1744187016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04883-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["4883"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04883-7","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"11 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved from the institutional ethics committee of King George\u2019s Medical University, Lucknow, India (Ethics committee approval number 377\/Ethics\/19.Date of approval: 02-04-19).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All study participants signed informed consent before enrolment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors consent to publication and grant the Publisher exclusive license of the full copyright.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}